SPECT imaging using 123I-Ioflupane (123I-Ioflupane-SPECT) provides information based on local binding of presynaptic dopamine transporters (DaTs) with 123I-Ioflupane, which has been shown to be highly correlated with PD progression7, 8. Here, SLC6A3 is linked to Parkinson disease.